Tunisian Clinical Registry on Chronic Kidney Disease in Hypertensive Patients
Launched by DACIMA CONSULTING · Aug 6, 2023
Trial Information
Current as of April 27, 2025
Completed
Keywords
ClinConnect Summary
This is national multicentric cross-sectional survey. The study will be carried out for one month at medical departments and ambulatory clinics of general physicians, family medicine specialists, endocrinologists, specialists in nutrition and metabolic diseases, nephrologists, internal medicine physicians, cardiologists, all physicians caring for non-diabetic hypertensive patients or any healthcare providers in charge of hypertensive patients.
A Steering Committee helps investigators to monitor their patient inclusions, performs audit trails and prepares the statistical analysis plan for t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Confirmed Hypertension
- • Follow-up at consultation at least for three months before enrollment date
- • Informed consent
- Exclusion Criteria:
- • Hypertension emergency
- • Pregnancy
- • Kidney transplanted subjects
- • Dialysis stage
About Dacima Consulting
Dacima Consulting is a leading clinical trial sponsor specializing in innovative solutions for the pharmaceutical and biotechnology industries. With a commitment to advancing healthcare, Dacima leverages cutting-edge technology and a team of experienced professionals to design, manage, and execute clinical trials efficiently and effectively. Their comprehensive services encompass protocol development, regulatory support, data management, and statistical analysis, ensuring high-quality results that facilitate the drug development process. Dacima Consulting is dedicated to enhancing patient outcomes through rigorous research, strategic collaboration, and a patient-centered approach.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tunis, , Tunisia
Patients applied
Trial Officials
Jannet Labidi, MD
Study Chair
Military Hospital of Tunis (Tunis, Tunisia)
Amel Harzallah, MD
Principal Investigator
University Hospital of Charles Nicolle (Tunis, Tunisia)
Awatef Azzabi, MD
Principal Investigator
University Hospital of Sahloul (Sousse, Tunisia)
Badreddine Ben Kaab, MD
Principal Investigator
La Marsa Internal Security Forces Hospital (Tunis, Tunisia)
Ikram Mami, MD
Principal Investigator
University Hospital of La Rabta (Tunis, Tunisia)
Lamia Rais, MD
Principal Investigator
University Hospital of La Rabta (Tunis, Tunisia)
Maissa Hadji Brahim, MD
Principal Investigator
University Hospital of Taher Sfar (Mahdia, Tunisia)
Mouna Hammouda, MD
Principal Investigator
University Hospital of Fattouma Bourguiba (Monastir, Tunisia)
Sahar Agrebi, MD
Principal Investigator
University Hospital of Charles Nicolle (Tunis, Tunisia)
Seifeddine Azaiez, MD
Principal Investigator
Private Clinic (Ben Arous, Tunisia)
Soumaya Chargui, MD
Principal Investigator
University Hospital of Charles Nicolle (Tunis, Tunisia)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported